Covaxin is 81 per cent effective in preventing Covid and can work against the UK variant of the virus, Bharat Biotech said Wednesday as it revealed a "first interim analysis" of Phase III trial...
from NDTV News - India-news https://ift.tt/30ecnxO
via IFTTT
Wednesday, March 3, 2021
Home »
IFTTT
,
NDTV News - India-news
» LIVE: Covaxin Phase 3 Trials Efficacy At 81 Per Cent, Says Bharat Biotech
0 comments:
Post a Comment